{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,7,23]],"date-time":"2024-07-23T00:54:15Z","timestamp":1721696055533},"reference-count":29,"publisher":"Japanese Society of Internal Medicine","issue":"18","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2016]]},"DOI":"10.2169\/internalmedicine.55.5790","type":"journal-article","created":{"date-parts":[[2016,9,14]],"date-time":"2016-09-14T22:08:59Z","timestamp":1473890939000},"page":"2537-2547","source":"Crossref","is-referenced-by-count":3,"title":["Repeat Catheter Ablation of Long-standing Persistent Atrial Fibrillation in Patients with a Total Atrial Fibrillation Duration of More Than 2 Years: Effects of the CHA&lt;sub&gt;2&lt;\/sub&gt;DS&lt;sub&gt;2&lt;\/sub&gt;-VASc Score and Estimated Glomerular Filtration Rate on the Outcomes"],"prefix":"10.2169","volume":"55","author":[{"given":"Qian","family":"Wang","sequence":"first","affiliation":[{"name":"Department of Cardiology, Shanghai Chest Hospital, Shanghai Jiao Tong University, China"},{"name":"Cardiovascular Research Laboratory, and Central Laboratory, Shanghai Chest Hospital, Shanghai Jiao Tong University, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shi-Li","family":"Jiang","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Laiyang Health School, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xu","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Shanghai Chest Hospital, Shanghai Jiao Tong University, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yi-Qing","family":"Yang","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Shanghai Chest Hospital, Shanghai Jiao Tong University, China"},{"name":"Cardiovascular Research Laboratory, and Central Laboratory, Shanghai Chest Hospital, Shanghai Jiao Tong University, China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"962","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Fuster V, Ryd\u00e9n LE, Cannom DS, et al. 2011 ACCF\/AHA\/HRS focused updates incorporated into the ACC\/AHA\/ESC 2006 Guidelines for the management of patients with atrial fibrillation: a report of the American College of Cardiology Foundation\/American Heart Association Task Force on Practice Guidelines developed in partnership with the European Society of Cardiology and in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society. J Am Coll Cardiol 57: e101-e198, 2011.","DOI":"10.1016\/j.jacc.2010.09.013"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Amerena JV, Walters TE, Mirzaee S, Kalman JM. Update on the management of atrial fibrillation. Med J Aust 199: 592-597, 2013.","DOI":"10.5694\/mja13.10191"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Chao TF, Tsao HM, Lin YJ, et al. Clinical outcome of catheter ablation in patients with nonparoxysmal atrial fibrillation: results of 3-year follow-up. Circ Arrhythm Electrophysiol 5: 514-520, 2012.","DOI":"10.1161\/CIRCEP.111.968032"},{"key":"4","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1093\/europace\/euq434","volume":"13","author":"JW McCready","year":"2011","unstructured":"4. McCready JW, Smedley T, Lambiase PD, et al. Predictors of recurrence following radiofrequency ablation for persistent atrial fibrillation. Europace 13: 355-361, 2011.","journal-title":"Europace","ISSN":"http:\/\/id.crossref.org\/issn\/1099-5129","issn-type":"print"},{"key":"5","doi-asserted-by":"publisher","unstructured":"5. Rostock T, Salukhe TV, Steven D, et al. Long-term single- and multiple-procedure outcome and predictors of success after catheter ablation for persistent atrial fibrillation. Heart Rhythm 8: 1391-1397, 2011.","DOI":"10.1016\/j.hrthm.2011.04.012"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Tilz RR, Rillig A, Thum AM, et al. Catheter ablation of long-standing persistent atrial fibrillation: 5-year outcomes of the Hamburg Sequential Ablation Strategy. J Am Coll Cardiol 60: 1921-1929, 2012.","DOI":"10.1016\/j.jacc.2012.04.060"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Weerasooriya R, Khairy P, Litalien J, et al. Catheter ablation for atrial fibrillation: are results maintained at 5 years of follow-up? J Am Coll Cardiol 57: 160-166, 2011.","DOI":"10.1016\/j.jacc.2010.05.061"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. W\u00f3jcik M, Berkowitsch A, Greiss H, et al. Repeated catheter ablation of atrial fibrillation: how to predict outcome? Circ J 77: 2271-2279, 2013.","DOI":"10.1253\/circj.CJ-13-0308"},{"key":"9","doi-asserted-by":"publisher","unstructured":"9. Piccini JP, Stevens SR, Chang Y, et al. Renal dysfunction as a predictor of stroke and systemic embolism in patients with nonvalvular atrial fibrillation: validation of the R<sub>2<\/sub>CHADS<sub>2<\/sub> index in the ROCKET AF (Rivaroxaban Once-daily, oral, direct factor Xa inhibition Compared with vitamin K antagonism for prevention of stroke and Embolism Trial in Atrial Fibrillation) and ATRIA (AnTicoagulation and Risk factors In Atrial fibrillation) study cohorts. Circulation 127: 224-232, 2013.","DOI":"10.1161\/CIRCULATIONAHA.112.107128"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Levey AS, Coresh J, Balk E, et al. National Kidney Foundation practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Ann Intern Med 139: 137-147, 2003.","DOI":"10.7326\/0003-4819-139-2-200307150-00013"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Liu X, Tan HW, Wang XH, et al. Efficacy of catheter ablation and surgical CryoMaze procedure in patients with long-lasting persistent atrial fibrillation and rheumatic heart disease: a randomized trial. Eur Heart J 31: 2633-2641, 2010.","DOI":"10.1093\/eurheartj\/ehq201"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Dorian P, Guerra PG, Kerr CR, et al. Validation of a new simple scale to measure symptoms in atrial fibrillation: the Canadian Cardiovascular Society Severity in Atrial Fibrillation scale. Circ Arrhythm Electrophysiol 2: 218-224, 2009.","DOI":"10.1161\/CIRCEP.108.812347"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Kirchhof P, Auricchio A, Bax J, et al. Outcome parameters for trials in atrial fibrillation: executive summary. Eur Heart J 28: 2803-2817, 2007.","DOI":"10.1093\/eurheartj\/ehm358"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Chao TF, Lin YJ, Tsao HM, et al. CHADS<sub>2<\/sub> and CHA<sub>2<\/sub>DS<sub>2<\/sub>-VASc scores in the prediction of clinical outcomes in patients with atrial fibrillation after catheter ablation. J Am Coll Cardiol 58: 2380-2385, 2011.","DOI":"10.1016\/j.jacc.2011.08.045"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Naccarelli GV, Panaccio MP, Cummins G, Tu N. CHADS<sub>2<\/sub> and CHA<sub>2<\/sub>DS<sub>2<\/sub>-VASc risk factors to predict first cardiovascular hospitalization among atrial fibrillation\/atrial flutter patients. Am J Cardiol 109: 1526-1533, 2012.","DOI":"10.1016\/j.amjcard.2012.01.371"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Kornej J, Hindricks G, Kosiuk J, et al. Comparison of CHADS<sub>2<\/sub>, R<sub>2<\/sub>CHADS<sub>2<\/sub>, and CHA<sub>2<\/sub>DS<sub>2<\/sub>-VASc scores for the prediction of rhythm outcomes after catheter ablation of atrial fibrillation: the Leipzig Heart Center AF Ablation Registry. Circ Arrhythm Electrophysiol 7: 281-287, 2014.","DOI":"10.1161\/CIRCEP.113.001182"},{"key":"17","doi-asserted-by":"publisher","unstructured":"17. Park JH, Joung B, Son NH, et al. The electroanatomical remodelling of the left atrium is related to CHADS<sub>2<\/sub>\/CHA<sub>2<\/sub>DS<sub>2<\/sub>VASc score and events of stroke in patients with atrial fibrillation. Europace 13: 1541-1549, 2011.","DOI":"10.1093\/europace\/eur135"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Verma A, Wazni OM, Marrouche NF, et al. Pre-existent left atrial scarring in patients undergoing pulmonary vein antrum isolation: an independent predictor of procedural failure. J Am Coll Cardiol 45: 285-292, 2005.","DOI":"10.1016\/j.jacc.2004.10.035"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Park JH, Pak HN, Choi EJ, et al. The relationship between endocardial voltage and regional volume in electroanatomical remodeled left atria in patients with atrial fibrillation: comparison of three-dimensional computed tomographic images and voltage mapping. J Cardiovasc Electrophysiol 20: 1349-1356, 2009.","DOI":"10.1111\/j.1540-8167.2009.01557.x"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Berkowitsch A, Kuniss M, Greiss H, et al. Impact of impaired renal function and metabolic syndrome on the recurrence of atrial fibrillation after catheter ablation: a long-term follow-up. Pacing Clin Electrophysiol 35: 532-543, 2012.","DOI":"10.1111\/j.1540-8159.2012.03350.x"},{"key":"21","doi-asserted-by":"publisher","unstructured":"21. Naruse Y, Tada H, Sekiguchi Y, et al. Concomitant chronic kidney disease increases the recurrence of atrial fibrillation after catheter ablation of atrial fibrillation: a mid-term follow-up. Heart Rhythm 8: 335-341, 2011.","DOI":"10.1016\/j.hrthm.2010.10.047"},{"key":"22","doi-asserted-by":"publisher","unstructured":"22. Tokuda M, Yamane T, Matsuo S, et al. Relationship between renal function and the risk of recurrent atrial fibrillation following catheter ablation. Heart 97: 137-142, 2011.","DOI":"10.1136\/hrt.2010.200824"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23. Chao TF, Lin YJ, Chang SL, et al. Associations between renal function, atrial substrate properties and outcome of catheter ablation in patients with paroxysmal atrial fibrillation. Circ J 75: 2326-2332, 2011.","DOI":"10.1253\/circj.CJ-11-0178"},{"key":"24","doi-asserted-by":"crossref","first-page":"S12","DOI":"10.1016\/j.hrthm.2008.02.025","volume":"5","author":"S Iravanian","year":"2008","unstructured":"24. Iravanian S, Dudley SC Jr. The renin-angiotensin-aldosterone system (RAAS) and cardiac arrhythmias. Heart Rhythm 5: S12-S17, 2008.","journal-title":"Heart Rhythm","ISSN":"http:\/\/id.crossref.org\/issn\/1547-5271","issn-type":"print"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25. Goette A, Staack T, R\u00f6cken C, et al. Increased expression of extracellular signal-regulated kinase and angiotensin-converting enzyme in human atria during atrial fibrillation. J Am Coll Cardiol 35: 1669-1677, 2000.","DOI":"10.1016\/S0735-1097(00)00611-2"},{"key":"26","doi-asserted-by":"publisher","unstructured":"26. Li J, Solus J, Chen Q, et al. Role of inflammation and oxidative stress in atrial fibrillation. Heart Rhythm 7: 438-444, 2010.","DOI":"10.1016\/j.hrthm.2009.12.009"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27. Thrall G, Lane D, Carroll D, Lip GY. Quality of life in patients with atrial fibrillation: a systematic review. Am J Med 119: 448.e1-448.e19, 2006.","DOI":"10.1016\/j.amjmed.2005.10.057"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28. Singh SN, Tang XC, Singh BN, et al; SAFE-T Investigators. Quality of life and exercise performance in patients in sinus rhythm versus persistent atrial fibrillation: a Veterans Affairs Cooperative Studies Program Substudy. J Am Coll Cardiol 48: 721-730, 2006.","DOI":"10.1016\/j.jacc.2006.03.051"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29. Reynolds MR, Walczak J, White SA, Cohen DJ, Wilber DJ. Improvements in symptoms and quality of life in patients with paroxysmal atrial fibrillation treated with radiofrequency catheter ablation versus antiarrhythmic drugs. Circ Cardiovasc Qual Outcomes 3: 615-623, 2010.","DOI":"10.1161\/CIRCOUTCOMES.110.957563"}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/55\/18\/55_55.5790\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,6,24]],"date-time":"2017-06-24T22:48:43Z","timestamp":1498344523000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/55\/18\/55_55.5790\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016]]},"references-count":29,"journal-issue":{"issue":"18","published-print":{"date-parts":[[2016]]}},"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.55.5790","relation":{},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"value":"0918-2918","type":"print"},{"value":"1349-7235","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016]]}}}